APA (7th ed.) Citation

Takakusagi, Y., Sugyo, A., Tsuji, A. B., Sudo, H., Yasunaga, M., Matsumura, Y., . . . Higashi, T. (2022). The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3. Elsevier.

Chicago Style (17th ed.) Citation

Takakusagi, Yoichi, Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Masahiro Yasunaga, Yasuhiro Matsumura, Fumio Sugawara, Kengo Sakaguchi, and Tatsuya Higashi. The Natural Sulfoglycolipid Derivative SQAP Improves the Therapeutic Efficacy of Tissue Factor-targeted Radioimmunotherapy in the Stroma-rich Pancreatic Cancer Model BxPC-3. Elsevier, 2022.

MLA (8th ed.) Citation

Takakusagi, Yoichi, et al. The Natural Sulfoglycolipid Derivative SQAP Improves the Therapeutic Efficacy of Tissue Factor-targeted Radioimmunotherapy in the Stroma-rich Pancreatic Cancer Model BxPC-3. Elsevier, 2022.